HEDGEHOG Signal in hepatocytes mediates macrophage recruitment: A new mechanism and potential therapeutic target for fatty liver disease

Hepatology

Volumn 63, Issue 4, 2016, Pages 1071-1073

  Seki, Ekihiro ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; SONIC HEDGEHOG PROTEIN; ANILIDE; PYRIDINE DERIVATIVE;

CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DRUG TARGETING; EDITORIAL; FATTY LIVER; HEDGEHOG; HEPATIC PROGENITOR CELL; HUMAN; LIVER CELL; LIVER FIBROSIS; MACROPHAGE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEATOSIS; ANIMAL; INFLAMMATION; LIPID DIET; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANILIDES; ANIMALS; DIET, HIGH-FAT; HEDGEHOG PROTEINS; INFLAMMATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PYRIDINES; SIGNAL TRANSDUCTION;

EID: 84955137566     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28381     Document Type: Editorial

References (8)

1. Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, Hunt S. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology 2015;62:1723-1730.
2. Arulanandan A, Ang B, Bettencourt R, Hooker J, Behling C, Lin GY, et al. Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2015;13:1513-1520.e1.
3. Kwon H, Song K, Han C, Chen W, Wang Y, Dash S, et al. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease. Hepatology 2016;63:1155-1169.
4. Omenetti A, Diehl AM. The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol 2008;294:G595-G598.
5. Chen Y, Choi SS, Michelotti GA, Chan IS, Swiderska-Syn M, Karaca GF, et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology 2012;143:1319-1329.e1-11.
6. Guy CD, Suzuki A, Zdanowicz M, Abdelmalek MF, Burchette J, Unalp A, Diehl AM; NASH CRN. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology 2012;55:1711-1721.
7. Guy CD, Suzuki A, Abdelmalek MF, Burchette JL, Diehl AM; Nash CRN. Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity. Hepatology 2015;61:98-107.
8. Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One 2013;8:e70599.